Loading data
EXELNasdaq
| Unit: USD | FY2026 | FY2025 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 2.32 bn USD | 2.17 bn USD | 1.83 bn USD | 1.61 bn USD | 1.43 bn USD |
| Cost of revenue | 83.7 m USD | 76.22 m USD | 72.55 m USD | 57.91 m USD | 52.87 m USD |
| Research and development expense | 825 m USD | 910.41 m USD | 1.04 bn USD | 891.81 m USD | 693.72 m USD |
| Selling, general and administrative expense | 518.73 m USD | 492.13 m USD | 542.71 m USD | 459.86 m USD | 401.72 m USD |
| Operating profit | 872.19 m USD | 604.62 m USD | 170.89 m USD | 201.48 m USD | 286.67 m USD |
| Income tax expense | 158.64 m USD | 160.37 m USD | 49.76 m USD | 52.07 m USD | 63.09 m USD |
| Net income (reported basis) | 782.6 m USD | 521.3 m USD | 207.8 m USD | 182.3 m USD | 231.1 m USD |
| Basic earnings per share | 2.88 USD/share | 1.8 USD/share | 0.65 USD/share | 0.57 USD/share | 0.73 USD/share |
| Diluted earnings per share | 2.78 USD/share | 1.76 USD/share | 0.65 USD/share | 0.56 USD/share | 0.72 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.